Form 4: STERIS Executive's Share Vesting & Tax Withholding

STERIS plc Senior VP Julia Madsen reported the withholding of 52 ordinary shares to cover tax liabilities upon the vesting of restricted stock units on October 1, 2025.

Summary

• Julia Madsen, Sr. VP and GM, Life Sciences at STERIS plc, reported a transaction on October 1, 2025.
• 52 ordinary shares were withheld to satisfy tax obligations upon the vesting of 144 restricted shares.
• These 144 restricted shares were originally awarded to Ms. Madsen on October 1, 2021.
• The shares were valued at the NYSE closing market price on October 1, 2025.
• Following this transaction, Ms. Madsen beneficially owns 10,710 ordinary shares.
• Of these, 4,003 ordinary shares remain restricted, with vesting scheduled between June 2026 and June 2028.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving the vesting of restricted stock and the withholding of shares for tax purposes, which is a standard and expected event in executive compensation. It does not indicate any significant positive or negative operational or financial developments for the company.

Positives

• Vesting of restricted shares indicates the successful completion of performance or tenure requirements for a portion of Ms. Madsen's long-term incentive compensation.
• The executive's continued beneficial ownership of 10,710 ordinary shares, including 4,003 restricted shares, aligns her interests with long-term shareholder value.

Negatives

• NA

Risks

• NA

Future Outlook

The filing details future vesting schedules for 4,003 restricted ordinary shares held by Ms. Madsen, with tranches lapsing between June 2026 and June 2028.

Management Comments

• NA

Industry Context

This filing is a routine disclosure of an insider transaction related to executive compensation, which is a standard practice across all publicly traded industries. It does not provide specific insights into broader industry trends for the life sciences or healthcare sectors.

Comparison to Industry Standards

• The withholding of shares for tax purposes upon vesting of restricted stock is a common and standard practice for executive compensation in publicly traded companies, aligning with typical industry compensation structures.

Related Party Transactions

• NA

Stakeholder Impact

• Shareholders: The transaction is a routine part of executive compensation, aligning management incentives with shareholder interests over the long term. It has no direct material impact on current share value or company operations.
• Employees: No direct impact on general employees.

Next Steps

• Vesting of 578 restricted ordinary shares on June 1, 2026.
• Vesting of 352 restricted ordinary shares on June 2, 2026.
• Vesting of 666 restricted ordinary shares on June 3, 2026.
• Vesting of 542 restricted ordinary shares on June 4, 2026.
• Vesting of 666 restricted ordinary shares on June 3, 2027.
• Vesting of 542 restricted ordinary shares on June 4, 2027.
• Vesting of 666 restricted ordinary shares on June 5, 2028.

Key Dates

Recommendation

This Form 4 filing details a routine vesting of restricted stock and the subsequent withholding of shares for tax purposes for a Senior VP. Such transactions are standard components of executive compensation plans and do not provide new material information that would alter an investment thesis for STERIS plc. The executive's continued significant beneficial ownership, including future restricted share vesting, maintains alignment with shareholder interests. Therefore, a "hold" recommendation is appropriate as this filing does not present a catalyst for a change in investment strategy.

Keywords

STERIS, STE, Form 4, insider transaction, stock vesting, restricted stock, executive compensation, Julia Madsen